SG11201810495YA - Method of prognosing and predicting breast cancer recurrence, markers employed therein and kit thereof - Google Patents
Method of prognosing and predicting breast cancer recurrence, markers employed therein and kit thereofInfo
- Publication number
- SG11201810495YA SG11201810495YA SG11201810495YA SG11201810495YA SG11201810495YA SG 11201810495Y A SG11201810495Y A SG 11201810495YA SG 11201810495Y A SG11201810495Y A SG 11201810495YA SG 11201810495Y A SG11201810495Y A SG 11201810495YA SG 11201810495Y A SG11201810495Y A SG 11201810495YA
- Authority
- SG
- Singapore
- Prior art keywords
- breast cancer
- international
- markers
- prognosing
- bangalore
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70585—CD44
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property 111111111111111111 1111111111010111110010101111101011101110111111111011110111111 Organization International Bureau (10) International Publication Number (43) International Publication Date ......0\" WO 2017/203444 Al 30 November 2017 (30.11.2017) WIPO I PCT (51) International Patent Classification: EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, GO1N 33/574 (2006.01) MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (21) International Application Number: TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, PCT/IB2017/053060 KM, ML, MR, NE, SN, TD, TG). (22) International Filing Date: Declarations under Rule 4.17: 24 May 2017 (24.05.2017) — of inventorship (Rule 4.17(iv)) (25) Filing Language: English Published: (26) Publication Language: English — with international search report (Art. 21(3)) (30) Priority Data: 201641017874 24 May 2016 (24.05.2016) IN (71) Applicants: ONCOSTEM DIAGNOSTICS PVT. LTD. [IN/IN]; 4, 2nd Floor, Aanand Towers, Raja Ram Mohan Roy Road, South Wing, Karnataka, Bangalore 560025 (IN). ONCOSTEM DIAGNOSTICS (MAURITIUS) PVT. LTD. [MU/MU]; 4th Floor, Raffles Tower, 19, Cybercity, Republic of Mauritius, Ebene (MU). (72) Inventors: BAKRE, Manjiri; 4, Purva Parkridge, Gosha- la Road, Mahadevpura Post, Karnataka, Bangalore 560048 (IN). RAMKUMAR, Charusheila; Flat 311, Vanshee Solitaire, 4th Main, 1st Cross, Chinnapnahalli, Marthahalli, Karnataka, Bangalore 560037 (IN). (74) Agent: RAVINDRANATH, Meenakshi et al.; K & S Part- ners Intellectual Property Attorneys, 4121/B, 6th Cross, 19A Main, HAL II Stage (Extension), Bangalore, Karnata- ka 560 038 (IN). = (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every = kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, 1-1 iv (54) Title: METHOD OF PROGNOSING AND PREDICTING BREAST CANCER RECURRENCE, MARKERS EMPLOYED 71. THEREIN AND KIT THEREOF 71' M (57) : The present disclosure relates to a method of prognosing and predicting breast cancer recurrence in patients. More N particularly, the present disclosure relates to a method of prognosing which stratifies early stage ER+/PR+ and Her2- breast cancer ---. patients with invasive ductal/lobular carcinoma of the breast into low risk or high risk for breast cancer recurrence by employing an IHC IN based assay which assesses or measures expression of a combination of 5 biomarkers and by employing a histopathological analysis 1-1 c;;;;) which assesses 3 clinical prognostic parameters. The present disclosure also relates to a combination of 5 biological markers and 3 ei clinical prognostics markers employed in the method for prognosis of breast cancer, a kit/test comprising the antibodies against said 0 markers for said prognosis and an IHC based assay system comprising said markers.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201641017874 | 2016-05-24 | ||
PCT/IB2017/053060 WO2017203444A1 (en) | 2016-05-24 | 2017-05-24 | Method of prognosing and predicting breast cancer recurrence, markers employed therein and kit thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201810495YA true SG11201810495YA (en) | 2018-12-28 |
Family
ID=59078121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201810495YA SG11201810495YA (en) | 2016-05-24 | 2017-05-24 | Method of prognosing and predicting breast cancer recurrence, markers employed therein and kit thereof |
Country Status (8)
Country | Link |
---|---|
US (1) | US10900968B2 (en) |
EP (1) | EP3465215B1 (en) |
CN (1) | CN109844534B (en) |
CA (1) | CA3025510C (en) |
ES (1) | ES2882875T3 (en) |
MY (1) | MY195697A (en) |
SG (1) | SG11201810495YA (en) |
WO (1) | WO2017203444A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3155592B1 (en) * | 2014-06-10 | 2019-09-11 | Leland Stanford Junior University | Predicting breast cancer recurrence directly from image features computed from digitized immunohistopathology tissue slides |
KR102315706B1 (en) * | 2020-03-30 | 2021-10-21 | 한국원자력의학원 | Biomarker composition for predicting cancer malignant prognosis induced by microplastic exposure |
US20240044900A1 (en) * | 2020-12-10 | 2024-02-08 | The Board Of Trustees Of The Leland Stanford Junior University | Features for determining ductal carcinoma in situ recurrence and progression |
CN117174338A (en) * | 2022-05-25 | 2023-12-05 | 中国医学科学院肿瘤医院 | Recurrence risk prognosis model for HER2 positive T1N0 breast invasive ductal carcinoma patient |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101057144A (en) * | 2004-09-22 | 2007-10-17 | 三路影像公司 | Methods and compositions for evaluating breast cancer prognosis |
CN103492590A (en) * | 2011-02-22 | 2014-01-01 | 卡里斯生命科学卢森堡控股有限责任公司 | Circulating biomarkers |
SG193630A1 (en) * | 2011-03-27 | 2013-10-30 | Oncostem Diagnostics Mauritius Pvt Ltd | Markers for identifying tumor cells, methods and kit thereof |
-
2017
- 2017-05-24 MY MYPI2018002098A patent/MY195697A/en unknown
- 2017-05-24 CA CA3025510A patent/CA3025510C/en active Active
- 2017-05-24 WO PCT/IB2017/053060 patent/WO2017203444A1/en active Search and Examination
- 2017-05-24 US US15/604,079 patent/US10900968B2/en active Active
- 2017-05-24 SG SG11201810495YA patent/SG11201810495YA/en unknown
- 2017-05-24 ES ES17731289T patent/ES2882875T3/en active Active
- 2017-05-24 CN CN201780045511.7A patent/CN109844534B/en active Active
- 2017-05-24 EP EP17731289.9A patent/EP3465215B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3465215B1 (en) | 2021-03-03 |
CN109844534B (en) | 2021-01-01 |
CN109844534A (en) | 2019-06-04 |
ES2882875T3 (en) | 2021-12-03 |
WO2017203444A1 (en) | 2017-11-30 |
MY195697A (en) | 2023-02-05 |
CA3025510C (en) | 2021-02-16 |
CA3025510A1 (en) | 2017-11-30 |
US20170343548A1 (en) | 2017-11-30 |
EP3465215A1 (en) | 2019-04-10 |
US10900968B2 (en) | 2021-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201808820QA (en) | Methods and kits for the diagnosis and risk stratification of patients with ischemia | |
SG11201810495YA (en) | Method of prognosing and predicting breast cancer recurrence, markers employed therein and kit thereof | |
SG11201809913PA (en) | Methods for detecting target nucleic acids in a sample | |
SG11201808494TA (en) | Signal light detection | |
SG11201903480TA (en) | Cell culture device system and methods of use thereof | |
SG11201805835WA (en) | Modified oncolytic virus | |
SG11201807252QA (en) | Anti-lag-3 antibodies | |
SG11201811048UA (en) | Single-cell transcript sequencing | |
SG11201805067PA (en) | Gas leak detection and location determination | |
SG11201900772YA (en) | Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors | |
SG11201408489PA (en) | Target detection and signal amplification | |
SG11201408434QA (en) | Targeted rna-seq methods and materials for the diagnosis of prostate cancer | |
SG11201804144UA (en) | High-throughput imaging-based methods for predicting cell-type-specific toxicity of xenobiotics with diverse chemical structures | |
SG11201805906WA (en) | Diagnostic and prognostic methods for cardiovascular diseases and events | |
SG11201908472VA (en) | Compositions and methods for activating nk cells | |
SG11201810544WA (en) | Detecting hematological disorders using cell-free dna in blood | |
SG11201810080UA (en) | System and method for 3d flight path display | |
SG11201806946VA (en) | Epigenomic profiling reveals the somatic promoter landscape of primary gastric adenocarcinoma | |
SG11201908075UA (en) | A microneedle device | |
SG11201808762XA (en) | Diagnostic methods for patient specific therapeutic decision making in cancer care | |
SG11201903139SA (en) | Methods for expression profile classification | |
SG11201407570SA (en) | Surface covering system and method for producing such a system | |
SG11201806432PA (en) | Methods for assessing risk of developing colorectal cancer | |
SG11201910195WA (en) | Methods for trapping and barcoding discrete biological units in hydrogel | |
SG11201806945SA (en) | Cancer epigenetic profiling |